VERIFIEDET Finance·6 Oct 2026neutral

Lupin launches fixed-dose triple combination inhaler for COPD in India

AI Summary

·Lupin Ltd has launched Formoflo-G MDI, a fixed-dose triple combination inhaler for COPD management in India.
·The inhaler combines three therapies into a single device for improved treatment outcomes.
·The Drug Controller General of India has approved the product, which aims to benefit over 55 million people with COPD in India.